Viscogliosi Brothers Watermark Holdings

The Viscogliosi brothers — Marc, John, and Anthony — jointly lead the firm's investment activities. They bring combined expertise in orthopedic surgery and healthcare finance. No outside CEO or CIO structure has been disclosed. Decision-making is concentrated within the founding principals.

The firm sources opportunities directly through the principals' clinical networks and participation in orthopedic surgery societies. Rather than relying on intermediated auctions, the brothers evaluate devices and biologics that surgeons bring to them from practice. This surgeon-to-surgeon channel is the firm's primary origination engine.

VB Watermark operates as a specialized private equity and venture firm, not as a single-family office. The principals manage pooled institutional and perhaps personal capital exclusively within a focused medtech mandate. It is externally marketed as an asset manager rather than a vehicle for solely family wealth.

VB Watermark makes direct investments into private companies developing musculoskeletal products. The firm has not publicly promoted a fund-of-funds program or allocations to outside venture capital managers. Its model is built on direct, often lead, equity positions in surgeon-founded enterprises.

The firm deploys capital from early-stage venture through growth and expansion rounds. Its sweet spot is the translational phase — taking a clinically validated idea and funding the regulatory, engineering, and initial commercialization steps. Later-stage investments are considered when a clear path to exit through strategic acquisition exists.

VB Watermark does not invest outside the musculoskeletal, orthopedic, and related medical device landscape. General healthcare IT, payer services, retail health, and non-device biotech are not within its mandate. The firm's value proposition is precisely this extreme subspecialization.

The precise composition of VB Watermark's capital base — institutional limited partners, family office co-investors, or principal commitments — has not been publicly detailed. The firm's principals are known to originate from a family of orthopedic surgeons, and their personal clinical reputations are central to the firm's market access.